ArticleScientific reports2025

Incidence and outcomes of neuromuscular immune-related adverse events in head and neck cancer patients treated with checkpoint inhibitors.

Stefanie Glaubitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.